Qingdao Baheal Medical INC.

Price Chart

Risk-Adjusted Performance

Qingdao Baheal Medical INC. (301015) Price Performance

Qingdao Baheal Medical INC. (301015) trades on SHE in CNY. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at CNY21.00, down 1.41% from the previous close.

Over the past year, 301015 has traded between a low of CNY16.79 and a high of CNY31.35. The stock has gained 2.0% over this period. It is currently 33.0% below its 52-week high.

Qingdao Baheal Medical INC. has a market capitalization of $11.64B.

About Qingdao Baheal Medical INC.

Qingdao Baheal Medical INC. engages in the research and development, production, wholesale, and retail of pharmaceutical products in China, the United States, Hong Kong, and the United Kingdom. The company offers bone health drugs under the D-Cal brand name; digestive drugs under the Mite brand name; liver disease drugs under the Fuzhenghuayu brand name; and urological drugs under the Betanli, Harle, and Wei Xi Kang brand names. It also provides ophthalmic drugs under the HYCOSAN brand name; tumor and other severe drugs under the Human Albumin and Xospata brand names; anti-aging and cosmeceuticals under the Quanis, Excellula, TRANSINO, and Qingchunbao brand names; diabetes drugs under the Naida, Feburic, and Naite brand names; respiratory and anti-infective products under the Klacid brand name; and medical nutrition under the Nutrasumma brand name. The company was incorporated in 2005 and is based in Qingdao, China. Qingdao Baheal Medical INC. is a subsidiary of BAHEAL Pharmaceutical Holdings Limited.